Home › Funds › Davern Capital Partners, LP › BNTX

Davern Capital Partners, LP position in BNTX

BIONTECH SE · Health Care

Davern Capital Partners, LP reported holding 682,148 shares of BNTX (BIONTECH SE) in its Q3 2026 13F filing — a position valued at US$67.1M, representing 13.04% of its reported portfolio and ranking #1 among its reported holdings. Davern Capital Partners, LP has disclosed BNTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)682.15K sh
Reported value held$67.06M
Portfolio Weight13.04%
First reportedQ4 2025
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Davern Capital Partners, LP's BNTX position evolved

Davern Capital Partners, LP first disclosed a stake in BNTX in Q4 2025 at 371,216 shares (US$35.3M). The position peaked in Q2 2026 at 754,550 shares, worth US$70.2M. Across 4 filings, Davern Capital Partners, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 682,148 shares valued at US$67.1M — a reduction of -72,402 shares quarter over quarter.. Notable position changes include a 147% increase in Q2 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 371.22K $35.34M New
Q1 2026 305.06K $27.11M Reduce
Q2 2026 754.55K $70.21M Add
Q3 2026 682.15K $67.06M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTX and 13F data

BNTX (BIONTECH SE) is a Health Care company. 33 other funds we track also report a position in BNTX — the largest reported positions include FLOSSBACH VON STORCH SE (US$207.1M), Temasek Holdings (Private) Ltd (US$140.1M), Logos Global Management LP (US$94.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTX

All BNTX fund holders →

FAQ

How long has Davern Capital Partners, LP held BNTX?

Davern Capital Partners, LP has disclosed BNTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Davern Capital Partners, LP's current position in BNTX?

As of Q3 2026, Davern Capital Partners, LP holds 682.15K shares of BNTX (BIONTECH SE), valued at $67.06M, representing 13.04% of its reported portfolio and ranking #1.

Has Davern Capital Partners, LP been buying or selling BNTX?

In the latest 13F filing (Q3 2026), Davern Capital Partners, LP reduced its position in BNTX. The position peaked in Q2 2026 at 754.55K shares.

Which other funds hold BNTX?

Other major institutional holders of BNTX include FLOSSBACH VON STORCH SE, Temasek Holdings (Private) Ltd, Logos Global Management LP, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.